Saudi Minister of the National Guard Prince Abdullah bin Bandar bin Abdulaziz will inaugurate on Wednesday the second Riyadh Global Medical Biotechnology Summit.

The two-day event will be held under the patronage of Prince Mohammed bin Salman bin Abdulaziz, Crown Prince and Prime Minister, and attract elite scientists and experts in the field.

The summit aims to discuss current practices and the future of the medical biotechnology sector to consolidate Saudi Arabia’s position as a global biotechnology portal.

In strategic partnership with the Ministry of Investment, the summit seeks to act as a global platform for proposing innovative models for the sector’s challenges, creating investment opportunities in the health industry, and signing agreements with major companies in this area in a way that positively reflects on human health in Saudi Arabia and the world at large.

To achieve these goals, biomedical and health research experts, doctors, pharmaceutical and biotechnological industry experts, representatives of health institutions, and research and development experts from around the world will participate in scientific panel discussions on five key themes: cell and gene therapy, vaccines for infectious diseases, vaccines for cancer, genomics and precision medicine for rare diseases, and clinical trials and real-world evidence.

The summit aligns with the Saudi Vision 2030, which seeks to strengthen the national economy based on research, knowledge, and research industries. It also represents an extension of the progress of national initiatives concerned with developing the Kingdom’s biotechnological medical system.